Prematurity and Respiratory Outcomes Program (PROP)
Public ClinicalTrials.gov record NCT01435187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In survivors of extreme prematurity to 36 weeks Post Menstrual Age (PMA), specific biologic, physiologic and clinical data obtained during the initial hospitalization will predict respiratory morbidity as defined by respiratory health care utilization and respiratory symptoms, between discharge and 1 year corrected age. This protocol describes a collaboratively developed multicenter study of very preterm infants from birth through the time of discharge from the Neonatal Intensive Care Unit (NICU) and up to 1 year of age, corrected for the degree of prematurity.
Study identification
- NCT ID
- NCT01435187
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 835 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 1 Day to 7 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- Mar 31, 2015
- Completion
- Feb 29, 2016
- Last update posted
- Nov 6, 2016
2011 – 2016
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Bates Summit Medical Center | Oakland | California | 94609 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Indiana University Health/Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| Washington Universitiy | St Louis | Missouri | 63130 | — |
| University of Buffalo | Buffalo | New York | 14260 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cincinnati University Hospital | Cincinnati | Ohio | 45219 | — |
| Good Samaritan Hospital | Cincinnati | Ohio | 45220 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | — |
| Jackson-Madison County General Hospital | Jackson | Tennessee | 38301 | — |
| Monroe Carell Jr Children's Hospital at Vanderbilt | Nashville | Tennessee | 37232 | — |
| University of Texas, Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01435187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01435187 live on ClinicalTrials.gov.